| Redox regulation of glial inflammatory response to lipopolysaccharide and interferonγ S Pawate, Q Shen, F Fan, NR Bhat Journal of neuroscience research 77 (4), 540-551, 2004 | 513 | 2004 |
| Presentations and outcomes of neurosarcoidosis: a study of 54 cases S Pawate, H Moses, S Sriram QJM: An International Journal of Medicine 102 (7), 449-460, 2009 | 337 | 2009 |
| Definition and consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis consortium consensus group BJ Stern, W Royal, JM Gelfand, DB Clifford, J Tavee, S Pawate, JR Berger, ... JAMA neurology 75 (12), 1546-1553, 2018 | 312 | 2018 |
| Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series JM Gelfand, MJ Bradshaw, BJ Stern, DB Clifford, Y Wang, TA Cho, ... Neurology 89 (20), 2092-2100, 2017 | 174 | 2017 |
| Diagnostic and therapeutic aspects of Hashimoto's encephalopathy I Olmez, H Moses, S Sriram, H Kirshner, AH Lagrange, S Pawate Journal of the Neurological Sciences 331 (1-2), 67-71, 2013 | 166 | 2013 |
| Extended interval dosing of natalizumab in multiple sclerosis LZ Ryerson, TC Frohman, J Foley, I Kister, B Weinstock-Guttman, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (8), 885-889, 2016 | 157 | 2016 |
| Neurosarcoidosis: pathophysiology, diagnosis, and treatment MJ Bradshaw, S Pawate, LL Koth, TA Cho, JM Gelfand Neurology: Neuroimmunology & Neuroinflammation 8 (6), e1084, 2021 | 144 | 2021 |
| Development of chemical exchange saturation transfer at 7T AN Dula, EM Asche, BA Landman, EB Welch, S Pawate, S Sriram, ... Magnetic Resonance in Medicine 66 (3), 831-838, 2011 | 115 | 2011 |
| Cranial base manifestations of neurosarcoidosis: a review of 305 patients ML Carlson, JR White Jr, M Espahbodi, DS Haynes, CLW Driscoll, ... Otology & Neurotology 36 (1), 156-166, 2015 | 94 | 2015 |
| Extended interval dosing of natalizumab: a two-center, 7-year experience R Bomprezzi, S Pawate Therapeutic advances in neurological disorders 7 (5), 227-231, 2014 | 85 | 2014 |
| Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised … JF Foley, G Defer, LZ Ryerson, JA Cohen, DL Arnold, H Butzkueven, ... The Lancet Neurology 21 (7), 608-619, 2022 | 70 | 2022 |
| Amide proton transfer CEST of the cervical spinal cord in multiple sclerosis patients at 3T S By, RL Barry, AK Smith, BD Lyttle, BA Box, FR Bagnato, S Pawate, ... Magnetic resonance in medicine 79 (2), 806-814, 2018 | 69 | 2018 |
| Untangling the R2* contrast in multiple sclerosis: A combined MRI-histology study at 7.0 Tesla F Bagnato, S Hametner, E Boyd, V Endmayr, Y Shi, V Ikonomidou, ... PLoS One 13 (3), e0193839, 2018 | 66 | 2018 |
| C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform S Pawate, NR Bhat Antioxidants & Redox Signaling 8 (5-6), 903-909, 2006 | 64 | 2006 |
| Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T AN Dula, S Pawate, RD Dortch, RL Barry, KM George-Durrett, BD Lyttle, ... Multiple Sclerosis Journal 22 (3), 320-328, 2016 | 60 | 2016 |
| Multiple sclerosis lesions affect intrinsic functional connectivity of the spinal cord BN Conrad, RL Barry, BP Rogers, S Maki, A Mishra, S Thukral, S Sriram, ... Brain 141 (6), 1650-1664, 2018 | 54 | 2018 |
| Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation K Kleinfeld, B Mobley, P Hedera, A Wegner, S Sriram, S Pawate Journal of neurology 260, 558-571, 2013 | 53 | 2013 |
| The role of infections in the pathogenesis and course of multiple sclerosis S Pawate, S Sriram Annals of Indian Academy of Neurology 13 (2), 80-86, 2010 | 50 | 2010 |
| The spectrum of Susac’s syndrome S Pawate, A Agarwal, H Moses, S Sriram Neurological sciences 30, 59-64, 2009 | 49 | 2009 |
| Expression, characterization, and purification of C-terminally hexahistidine-tagged thromboxane A2 receptors S Pawate, KL Schey, GP Meier, ME Ullian, DE Mais, PV Halushka Journal of Biological Chemistry 273 (35), 22753-22760, 1998 | 34 | 1998 |
